![\"\"](\"https:\/\/www.oraldna.com\/trends-in-salivary-testing\/wp-content\/uploads\/2020\/10\/Antibiotic-Option-Blog.jpeg\")
<\/p>\n<\/p>\n
MyPerioPath\u00ae results provide guidance to the health care provider regarding the bacterial cause to a patient\u2019s periodontal disease and\/or risk of complicating other systemic diseases such as cardiovascular disease1<\/sup><\/a>, diabetes2<\/sup><\/a>, certain cancers3<\/sup><\/a>, brain health4<\/sup><\/a>, musculoskeletal health5<\/sup><\/a>, and pregnancy outcomes6<\/sup><\/a>. The health care provider will consider several modes of therapy to help address the pathogenic bacteria and the following therapy will conduct a post-therapy test to objectively measure the impact of the applied therapy on the bacterial profile.<\/p>\n The MyPerioPath\u00ae treatment consideration section of the report provides an overview of possible therapies to be determined by the health care provider. This section is thorough; however, it does not include all therapy options. A health care provided should never feel limited by these considerations as they are just that – \u201cconsiderations.\u201d<\/p>\n Some health care providers opt to utilize the systemic antibiotic option in addition to mechanical debridement. The systemic antibiotic option printed on the report refers to a resource labeled the MyPerioPath\u00ae Antibiotic Options. In most cases, when the pathogenic bacteria exceed the Therapeutic Threshold (bold black lines<\/a>), an algorithm is applied for selecting the evidence-based recommendation(s). If the bacteria levels do not reach the threshold or the option was omitted intentionally and the provider assesses the patient would benefit from antibiotic therapy, then the health care provider can refer to the MyPerioPath\u00ae Antibiotic Options for a possible antibiotic selection consideration.<\/p>\n The below video highlights the MyPerioPath\u00ae Antibiotic Option.<\/p>\n